phenylalanine has been researched along with bortezomib in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Berkers, CR; Groll, M; Ovaa, H; Ploegh, HL | 1 |
Hattori, Y; Ishimura, M; Kirihata, M; Ohta, Y; Ono, K; Takenaka, H; Tanaka, H; Watanabe, T | 1 |
de Bruin, G; Florea, BI; Hoogendoorn, S; Mazurek, J; Mock, ED; Overkleeft, HS; van den Nieuwendijk, AM; van der Marel, GA | 1 |
Emeh, P; Eskelinen, A; Gebraad, A; Heckman, CA; Kuismanen, K; Lehmann, F; Manninen, M; Miettinen, JJ; Miettinen, S; Nupponen, NN; Ohlsbom, R; Pakarinen, TK; Slipicevic, A | 1 |
4 other study(ies) available for phenylalanine and bortezomib
Article | Year |
---|---|
Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Catalytic Domain; Crystallization; Leucine; Mammals; Models, Molecular; Peptides; Phenylalanine; Proteasome Endopeptidase Complex; Protein Structure, Quaternary; Pyrazinamide; Pyrazines; Structure-Activity Relationship; Substrate Specificity; Yeasts | 2006 |
Detection of boronic acid derivatives in cells using a fluorescent sensor.
Topics: Antineoplastic Agents; Boron; Boron Compounds; Boronic Acids; Bortezomib; Cell Line, Tumor; Chelating Agents; Fluorescent Dyes; Humans; Optical Imaging; Phenylalanine; Spectrometry, Fluorescence | 2015 |
Enantioselective synthesis of adamantylalanine and carboranylalanine and their incorporation into the proteasome inhibitor bortezomib.
Topics: Adamantane; Boron Compounds; Bortezomib; Cell Line, Tumor; Humans; Phenylalanine; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Stereoisomerism; Sulfonium Compounds | 2016 |
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen.
Topics: Bone Marrow; Bortezomib; Doxorubicin; Humans; Melphalan; Mesenchymal Stem Cells; Multiple Myeloma; Phenylalanine | 2022 |